TECX

Tectonic Therapeutic, Inc.

NASDAQ: TECX · HEALTHCARE · BIOTECHNOLOGY

$28.81

+3.61% today

Updated 2026-06-03

Market cap

$553.62M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.46

Dividend yield

—

52W range

$14 – $36

Volume

0.2M

Market cap

$553.62M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.46

Dividend yield

—

52W range

$14 – $36

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

8.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

14.6

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$78.44

+172.27%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy9 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Altman Z 14.55 — safe zone

+ Debt/equity 0.02x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-18.43M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-32.18M	$-42.82M	$-57.98M	$-74.15M	$-25.24M
EPS	—	—	—	—	$-4.46
Free cash flow	$-97.47M	$-40.96M	$-59.24M	$-60.29M	$-18.43M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TECX	$553.62M	28	4.3	3.0	5.0	8.5	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Tectonic Therapeutic, Inc. trades at $28.81. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 14.55, it sits in the safe zone.

Frequently asked questions

What is Tectonic Therapeutic, Inc.'s stock price?

Tectonic Therapeutic, Inc. (TECX) trades at $28.81.

Is Tectonic Therapeutic, Inc. overvalued?

Tectonic Therapeutic, Inc. carries a Smart Value Score of 28/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Tectonic Therapeutic, Inc. (TECX)?

The 12-month analyst consensus target is $78.44, about 172.3% above the current $28.81. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Tectonic Therapeutic, Inc.'s Altman Z-Score is 14.55, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-36.23%

Beta—

50D MA$28.99

200D MA$22.91

Shares out0.02B

Float0.01B

Short ratio—

Avg volume0.2M

Performance

1 week+0.00%

1 month-1.35%

3 months-14.68%

YTD+36.24%

1 year—

3 years—

5 years—

Compare

TECX vs LLY →TECX vs JNJ →TECX vs ABBV →Stock screener →